Dose Escalation of Interleukin-1 (IL-7) Added on Antiviral Treatment and Vaccination in HBeAg-negative Chronic Hepatitis B Virus (HBV) Infected Patients (CONVERT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT01027065

Recruitment Status : Unknown

Verified October 2012 by Cytheris SA.
Recruitment status was: Active, not recruiting

First Posted : December 7, 2009

Last Update Posted : October 18, 2012

View this study on the modernized ClinicalTrials.gov

Sponsor:

Information provided by (Responsible Party):

Cytheris SA

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Unknown
Estimated Primary Completion Date :	November 2012
Estimated Study Completion Date :	March 2013

To Top